Internal Medicine, Gastroenterology · Longmont, CO
NPI
1568467801
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1925 W Mountain View Ave
Longmont, CO, 80501
Phone (303) 776-1234
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
1,385 services
Medicare patients, 2024
375
Average age 72
Drug cost, 2024
$237K
836 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nuzhat Iqbal was code 45385 (colonoscopy - lesion removal), 155 times for 155 patients. In total Nuzhat Iqbal billed 1,385 services in 42 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 155 | 155 | $156.66 | $24K |
| 45380 Lower GI Endoscopy - Other | Facility | 155 | 155 | $53.11 | $8,231 |
| 43239 Upper GI Endoscopy | Facility | 124 | 121 | $44.04 | $5,462 |
| 45381 Lower GI Endoscopy - Other | Facility | 107 | 106 | $15.66 | $1,675 |
| 45390 Lower GI Endoscopy - Other | Facility | 81 | 81 | $285.11 | $23K |
| 99214 Office E&M - Established | Office | 57 | 47 | $89.86 | $5,122 |
| 43249 Upper GI Endoscopy | Facility | 44 | 43 | $71.47 | $3,145 |
| 36415 Venipuncture Blood Collection | Office | 38 | 29 | $8.65 | $329 |
| 43236 Upper GI Endoscopy | Facility | 32 | 31 | $10.62 | $340 |
| 43251 Upper GI Endoscopy | Facility | 32 | 31 | $124.33 | $3,979 |
| 82306 Clinical Chemistry | Office | 26 | 21 | $28.36 | $737 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 24 | 24 | $179.07 | $4,298 |
| 85025 Blood Count | Office | 22 | 16 | $7.61 | $167 |
| 80053 Clinical Chemistry | Office | 22 | 18 | $10.08 | $222 |
| 83735 Clinical Chemistry | Office | 20 | 17 | $6.38 | $128 |
By year: 2022 $100K for 1,710 services; 2023 $91K for 1,218 services; 2024 $93K for 1,385 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 38 | 29 | $8.65 | $329 |
| 82306 Clinical Chemistry | 26 | 21 | $28.36 | $737 |
| 80053 Clinical Chemistry | 22 | 18 | $10.08 | $222 |
| 85025 Blood Count | 22 | 16 | $7.61 | $167 |
| 83735 Clinical Chemistry | 20 | 17 | $6.38 | $128 |
Medicare prescription drug claims, 2024
In 2024, the drug Nuzhat Iqbal prescribed most often to Medicare patients was Ondansetron Hcl, with 141 prescriptions and refills. In total Nuzhat Iqbal wrote 836 Medicare prescriptions that cost $237K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 141 | 141 | 139 | $302 |
| Omeprazole Generic | 109 | 238 | 31 | $2,956 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 94 | 105 | 92 | $6,354 |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 94 | 94 | 93 | $11K |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 87 | 87 | 86 | $14K |
| Famotidine Generic | 56 | 156 | 18 | $1,166 |
| Mesalamine Generic | 35 | 87 | Under 11 | $21K |
| Pantoprazole Sodium Generic | 33 | 93 | Under 11 | $706 |
| Ondansetron Odt Ondansetron | 17 | 17 | 17 | $90.58 |
| Linzess Linaclotide | 16 | 26 | Under 11 | $14K |
| Azathioprine Generic | 16 | 30 | Under 11 | $517 |
| Sucralfate Generic | 14 | 14 | Under 11 | $4,627 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 14 | 14 | 14 | $332 |
| Mesalamine Er Mesalamine | 13 | 25 | Under 11 | $2,394 |
| Humira Pen Adalimumab | 13 | 13 | Under 11 | $88K |
Brand drugs: 273 claims; generic drugs: 563 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Nuzhat Iqbal were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.